Intragenic somatic mutations of cyclin D1 are rare, but a polymorphism of cyclin D1 that occurs in a splice donor site has been epidemiologically linked to increased cancer risk or poor prognosis in a number of tumor types (reviewed in [7]). This evidence concerns the gene CCND1 and neoplasm.